XML 47 R25.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Shareholders’ Equity (Deficit) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Shareholders' Equity (Deficit) [Abstract] |
Schedule of Share Capital | The share capital as of December 31, 2023 and 2022, is composed of as follows:
|  | Number of shares |
|  | Authorized |  |  | Issued and outstanding |
|  | December 31, 2023 |  |  | December 31, 2022 |  |  | December 31, 2023 |  |  | December 31, 2022 |
Ordinary shares, NIS 0.01 par value |  |  | 50,000,000 |  |  |  | 50,000,000 |  |  |  | 20,387,428 |  |  |  | 15,049,720 |
Schedule of Options Activity | Below is a summary of the Company’s options activity and related information with respect to options granted to employees during the years ended December 31, 2023 and 2022.
|  | Year ended December 31, |  |  | Year ended December 31, |
|  | 2023 |  |  | 2022 |
|  | Amount of options |  |  | Weighted average exercise price |  |  | Amount of options |  |  | Weighted average exercise price |
Outstanding - beginning of the year |  |  | 988,264 |  |  | $ | 0.563 |  |  |  | 863,264 |  |  | $ | 0.614 |
Granted |  |  | *471,500 |  |  | $ | 1.224 |  |  |  | 145,000 |  |  | $ | 0.184 |
Exercised |  |  | - |  |  | $ | - |  |  |  | (4,666 | ) |  | $ | 0.003 |
Expired or forfeited |  |  | (5,000 | ) |  | $ | 0.664 |  |  |  | (15,334 | ) |  | $ | 0.003 |
Outstanding - end of the year |  |  | 1,454,764 |  |  | $ | 0.777 |  |  |  | 988,264 |  |  | $ | 0.563 |
Exercisable at end of year |  |  | 889,125 |  |  | $ | 0.612 |  |  |  | 753,236 |  |  | $ | 0.703 |
* | Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company’s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.
Schedule of weighted-Average Assumptions | The following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:
|  | 2023 |
Expected dividend yield |  |  | 0 | %
Expected stock price volatility |  |  | 55.0 | %
Risk free interest rate |  |  | 4.10 | %
Expected life of options |  |  | 6.25 |
Schedule of Options to Consultants | The Company’s outstanding options to consultants as of December 31, 2023 were as follows:
Issuance date |  | In connection with |  | No. of options issued |  |  | Exercise price |  |  | No. of options exercisable |
2015 |  | Rendered services |  |  | 110,655 |  |  | $ | 0.003 |  |  |  | 110,655 |
2017 |  | Rendered services |  |  | 36,885 |  |  | $ | 0.003 |  |  |  | 36,885 |
2021 |  | Rendered services |  |  | 69,090 |  |  | $ | 0.003-$2.25 |  |  |  | 69,090 |
2023* |  | Rendered services |  |  | 100,000 |  |  | $ | 0.546 |  |  |  | 37,778 |
* | On April 27, 2023, the Company’s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.
Schedule of Share-Based Compensation Expenses | The share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:
|  | December 31 |
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | U.S. dollars in thousands |
Research and development expenses |  |  | 83 |  |  |  | 180 |  |  |  | 105 |
Sales and marketing expenses |  |  | 61 |  |  |  | 401 |  |  |  | 111 |
General and administrative expenses |  |  | 97 |  |  |  | 209 |  |  |  | 83 |
|  |  | 241 |  |  |  | 790 |  |  |  | 299 |
Schedule of Issuance of Equity Warrants to Investors and Associate | Equity Warrants to investors and associated with the IPO, as of December 31, 2023:
Number of warrants/ options |  |  | Issuance date |  | Exercise price |  |  | Exercise ratio |  | Expiration date |  | Notes
| 7,860,861 |  |  | September 13, 2022 |  | $ | 2.00 |  |  | Each warrant is exercisable into 1 Ordinary Share |  | 5 years following the issuance date |  | Registered for trading (*)
| 671,687 |  |  | September 15, 2022 |  | $ | 5.29 |  |  | Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above |  | 18 months following the issuance date |  | Owned by April 2021 investors
| 187,500 |  |  | September 15, 2022 |  | $ | 5.31 |  |  | Each warrant is exercisable into 1 Ordinary Share |  | 5 years following the issuance date |  | Owned by underwriter
| 23,640 |  |  | September 15, 2022 |  | $ | 4.23 |  |  | Each warrant is exercisable into 1 Ordinary Share |  | 10 years following the issuance date |  | Owned by the legal advisor
(*) The warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased upon such exercise.

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in Issuance of equity warrants to investors and associat. + References No definition available. + Details
Name: | wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock
Namespace Prefix: | wlds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of stock options issued to consultants. + References No definition available. + Details
Name: | wlds_ScheduleOfOptionsToConsultantsTableTextBlock
Namespace Prefix: | wlds_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration